Last Updated : October 1, 2015
Details
FilesGeneric Name:
Elosulfase alfa
Project Status:
Complete
Therapeutic Area:
Mucopolysaccharidosis IVA (Morquio A syndrome)
Manufacturer:
BioMarin Pharmaceutical (Canada) Inc.
Call for patient/clinician input open:
Brand Name:
Vimizim
Project Line:
Reimbursement Review
Project Number:
SR0456-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Resubmission
Indications:
Mucopolysaccharidosis IVA (Morquio A syndrome)
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : October 1, 2015